Literature DB >> 23459998

[IgG4-related disease].

J Loock1, B Manger.   

Abstract

IgG4-related disease is a systemic fibroinflammatory syndrome of unknown etiology characterized by local inflammatory swelling and tumefactive lesions in one or several organs. It unifies several diseases previously thought to be unrelated. Recently, diagnostic criteria for the disease have been formulated and were complemented by an international consensus on histopathological assessment. In general, the disease activity can be rapidly controlled by high doses of prednisolone (0.6 mg/kg body weight); however, relapses, either local or in other regions, are frequent during tapering of the steroid dose. Commonly used steroid-sparing agents are only partially effective. Persistent local inflammatory activity may result in permanent organ damage. In refractory cases rituximab treatment has been used with good success. In the long-term care of affected patients a probable increased risk of malignancies (e.g. solid tumors and lymphoma) requires attention.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23459998     DOI: 10.1007/s00393-012-1104-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  47 in total

1.  Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases.

Authors:  Motohisa Yamamoto; Tetsuya Tabeya; Yasuyoshi Naishiro; Hidetaka Yajima; Keisuke Ishigami; Yui Shimizu; Mikiko Obara; Chisako Suzuki; Kentaro Yamashita; Hiroyuki Yamamoto; Toshiaki Hayashi; Shigeru Sasaki; Toshiaki Sugaya; Tadao Ishida; Ken-Ichi Takano; Tetsuo Himi; Yasuo Suzuki; Norihiro Nishimoto; Saho Honda; Hiroki Takahashi; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Mod Rheumatol       Date:  2011-09-28       Impact factor: 3.023

2.  Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis.

Authors:  Takashi Tomiyama; Kazushige Uchida; Mitsunobu Matsushita; Tsukasa Ikeura; Toshiro Fukui; Makoto Takaoka; Akiyoshi Nishio; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2010-12-25       Impact factor: 7.527

3.  B lymphocyte stimulator activates p38 mitogen-activated protein kinase in human Ig class switch recombination.

Authors:  Takechiyo Yamada; Ke Zhang; Akiko Yamada; Daocheng Zhu; Andrew Saxon
Journal:  Am J Respir Cell Mol Biol       Date:  2005-01-24       Impact factor: 6.914

4.  Identification of a novel antibody associated with autoimmune pancreatitis.

Authors:  Luca Frulloni; Claudio Lunardi; Rita Simone; Marzia Dolcino; Chiara Scattolini; Massimo Falconi; Luigi Benini; Italo Vantini; Roberto Corrocher; Antonio Puccetti
Journal:  N Engl J Med       Date:  2009-11-26       Impact factor: 91.245

5.  Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis.

Authors:  Hideaki Hamano; Norikazu Arakura; Takashi Muraki; Yayoi Ozaki; Kendo Kiyosawa; Shigeyuki Kawa
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

6.  Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease.

Authors:  Wah Cheuk; Hunter K L Yuen; Alexander C L Chan; Lee-Yung Shih; Tseng-Tong Kuo; Ming-Wai Ma; Yan-Fai Lo; Wai-Kong Chan; John K C Chan
Journal:  Am J Surg Pathol       Date:  2008-08       Impact factor: 6.394

Review 7.  Immunoglobulin G4: an odd antibody.

Authors:  R C Aalberse; S O Stapel; J Schuurman; T Rispens
Journal:  Clin Exp Allergy       Date:  2009-02-13       Impact factor: 5.018

8.  Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis.

Authors:  Yoh Zen; Takahiko Fujii; Kenichi Harada; Mitsuhiro Kawano; Kazunori Yamada; Masayuki Takahira; Yasuni Nakanuma
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

Review 9.  Role of basophils in the initiation of Th2 responses.

Authors:  Caroline L Sokol; Ruslan Medzhitov
Journal:  Curr Opin Immunol       Date:  2010-02-09       Impact factor: 7.486

10.  IgG4 immune response in Churg-Strauss syndrome.

Authors:  Augusto Vaglio; Johanna D Strehl; Bernhard Manger; Federica Maritati; Federico Alberici; Christian Beyer; Jürgen Rech; Renato A Sinico; Francesco Bonatti; Luisita Battistelli; Jörg H W Distler; Georg Schett; Jochen Zwerina
Journal:  Ann Rheum Dis       Date:  2011-11-25       Impact factor: 27.973

View more
  6 in total

1.  [Interdisciplinary approach in a patient with IgG4-associated Mikulicz's disease].

Authors:  K Triantafyllias; N Karaiskaki; T Hansen; P R Galle; A Schwarting
Journal:  Z Rheumatol       Date:  2013-11       Impact factor: 1.372

2.  [A 70-year-old patient with painful exophthalmos and double vision].

Authors:  J Dieckow; W Rasche; I Sterker; S Schob; F M Rasche; P Wiedemann
Journal:  Ophthalmologe       Date:  2016-01       Impact factor: 1.059

Review 3.  [Immunoglobulin G4 (IgG4)-related disease. A review of head and neck manifestations].

Authors:  A Agaimy; S Ihrler
Journal:  Pathologe       Date:  2014-03       Impact factor: 1.011

Review 4.  [IgG4-associated diseases].

Authors:  M Diller; K Evert; M Fleck
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

5.  [Ocular myositis as a rare cause of vision loss].

Authors:  J D Rollnik; H Requadt
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

Review 6.  [Interstitial nephritis in rheumatic diseases].

Authors:  P Korsten; G A Müller
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.